Adaptable modification of adenoviral tropism using a bifunctional ligand protein

Yibing Li, Xiao Ming Yao, Ly Hong-Brown, Stephen M. Massa

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In order to target recombinant adenovirus (AdV), we have developed a new strategy using a fusion ligand protein comprising coxsackievirus/adenovirus receptor (CAR), and the antibody Fc-binding domain from protein A in vitro testing with this ligand shows that it blocks viral gene transduction and, when coupled with anti-ICAM-1 IgG, redirects AdV to endothelial cells that are induced to express ICAM-1. Because the protein A Fc-binding domain will bind to any immunoglobulin, the current strategy can be adapted to target a wide variety of tissues or cells as long as an antibody species that recognizes a membrane marker on target tissue or cell is present. This concept may be further expanded to other viruses that employ peptide receptors. These membrane receptors can be fused to the Fc-binding domain to create a variety of bifunctional ligands for targeting recombinant viruses in gene therapy.

Original languageEnglish (US)
Pages (from-to)223-230
Number of pages8
JournalVirus Research
Volume91
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Tropism
Staphylococcal Protein A
Intercellular Adhesion Molecule-1
Ligands
Adenoviridae
Viruses
Proteins
Peptide Receptors
Membranes
Viral Genes
Antibodies
Enterovirus
Genetic Therapy
Immunoglobulins
Carrier Proteins
Endothelial Cells
Immunoglobulin G

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Virology
  • Infectious Diseases

Cite this

Li, Yibing ; Yao, Xiao Ming ; Hong-Brown, Ly ; Massa, Stephen M. / Adaptable modification of adenoviral tropism using a bifunctional ligand protein. In: Virus Research. 2003 ; Vol. 91, No. 2. pp. 223-230.
@article{721c1ebf55e44ccfa824b6ae348a9bd9,
title = "Adaptable modification of adenoviral tropism using a bifunctional ligand protein",
abstract = "In order to target recombinant adenovirus (AdV), we have developed a new strategy using a fusion ligand protein comprising coxsackievirus/adenovirus receptor (CAR), and the antibody Fc-binding domain from protein A in vitro testing with this ligand shows that it blocks viral gene transduction and, when coupled with anti-ICAM-1 IgG, redirects AdV to endothelial cells that are induced to express ICAM-1. Because the protein A Fc-binding domain will bind to any immunoglobulin, the current strategy can be adapted to target a wide variety of tissues or cells as long as an antibody species that recognizes a membrane marker on target tissue or cell is present. This concept may be further expanded to other viruses that employ peptide receptors. These membrane receptors can be fused to the Fc-binding domain to create a variety of bifunctional ligands for targeting recombinant viruses in gene therapy.",
author = "Yibing Li and Yao, {Xiao Ming} and Ly Hong-Brown and Massa, {Stephen M.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1016/S0168-1702(02)00274-5",
language = "English (US)",
volume = "91",
pages = "223--230",
journal = "Virus Research",
issn = "0168-1702",
publisher = "Elsevier",
number = "2",

}

Adaptable modification of adenoviral tropism using a bifunctional ligand protein. / Li, Yibing; Yao, Xiao Ming; Hong-Brown, Ly; Massa, Stephen M.

In: Virus Research, Vol. 91, No. 2, 01.02.2003, p. 223-230.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adaptable modification of adenoviral tropism using a bifunctional ligand protein

AU - Li, Yibing

AU - Yao, Xiao Ming

AU - Hong-Brown, Ly

AU - Massa, Stephen M.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - In order to target recombinant adenovirus (AdV), we have developed a new strategy using a fusion ligand protein comprising coxsackievirus/adenovirus receptor (CAR), and the antibody Fc-binding domain from protein A in vitro testing with this ligand shows that it blocks viral gene transduction and, when coupled with anti-ICAM-1 IgG, redirects AdV to endothelial cells that are induced to express ICAM-1. Because the protein A Fc-binding domain will bind to any immunoglobulin, the current strategy can be adapted to target a wide variety of tissues or cells as long as an antibody species that recognizes a membrane marker on target tissue or cell is present. This concept may be further expanded to other viruses that employ peptide receptors. These membrane receptors can be fused to the Fc-binding domain to create a variety of bifunctional ligands for targeting recombinant viruses in gene therapy.

AB - In order to target recombinant adenovirus (AdV), we have developed a new strategy using a fusion ligand protein comprising coxsackievirus/adenovirus receptor (CAR), and the antibody Fc-binding domain from protein A in vitro testing with this ligand shows that it blocks viral gene transduction and, when coupled with anti-ICAM-1 IgG, redirects AdV to endothelial cells that are induced to express ICAM-1. Because the protein A Fc-binding domain will bind to any immunoglobulin, the current strategy can be adapted to target a wide variety of tissues or cells as long as an antibody species that recognizes a membrane marker on target tissue or cell is present. This concept may be further expanded to other viruses that employ peptide receptors. These membrane receptors can be fused to the Fc-binding domain to create a variety of bifunctional ligands for targeting recombinant viruses in gene therapy.

UR - http://www.scopus.com/inward/record.url?scp=0037308647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037308647&partnerID=8YFLogxK

U2 - 10.1016/S0168-1702(02)00274-5

DO - 10.1016/S0168-1702(02)00274-5

M3 - Article

C2 - 12573501

AN - SCOPUS:0037308647

VL - 91

SP - 223

EP - 230

JO - Virus Research

JF - Virus Research

SN - 0168-1702

IS - 2

ER -